The pathologic development of heterotopic ossification (HO) is well described in patients with extensive trauma or with hyperactivating mutations of the bone morphogenetic protein (BMP) receptor ACVR1. However, identification of progenitor cells contributing to this process remains elusive. Here we show that connective tissue cells contribute to a substantial amount of HO anlagen caused by trauma using postnatal, tamoxifen-inducible, scleraxis-lineage restricted reporter mice (Scx-creERT2/tdTomato fl/fl ). When the scleraxis-lineage is restricted specifically to adults prior to injury marked cells contribute to each stage of the developing HO anlagen and coexpress markers of endochondral ossification (Osterix, SOX9). Furthermore, these adult preinjury restricted cells coexpressed mesenchymal stem cell markers including PDGFRa, Sca1, and S100A4 in HO. When constitutively active ACVR1 (caACVR1) was expressed in scx-cre cells in the absence of injury (Scx-cre/caACVR1 fl/fl ), tendons and joints formed HO. Postnatal lineage-restricted, tamoxifeninducible caACVR1 expression (Scx-creERT2/caACVR1 fl/fl ) was sufficient to form HO after directed cardiotoxin-induced muscle injury. These findings suggest that cells expressing scleraxis within muscle or tendon contribute to HO in the setting of both trauma or hyperactive BMP receptor (e.g., caACVR1) activity. STEM CELLS 2017;35:705-710 
INTRODUCTION
Heterotopic ossification (HO) is a pathologic process in which ectopic bone forms within muscle, tendons, or other soft tissues. Clinically, HO lesions develop at sites of musculoskeletal injury or burns, and in patients with hyperactive BMP receptor signaling [1] . Because HO forms in several tissue types, identification of common progenitors has been an area of growing interest. Several different progenitor cells have been evaluated in the context of BMP-induced HO models within muscle. Using lineage-tracing mice, Tie21 cells have been noted to undergo osteogenic differentiation in vivo [2, 3] . These Tie21 cells have been shown to be muscleresident CD31-/CD45-/PDGFRa1/Sca11 cells suggesting they are mesenchymal stem cells and not endothelial cells as initially thought [4] . The contribution of Glast-cre cells that reside within the muscle interstitium has also been evaluated. These cells coexpress mesenchymal markers including PDGFRa and S100A4, and also appear to contribute to different stages of HO [5] . In these models, however, BMP activity is not limited to the contributing MSCs, and it is not clear whether BMP is required to engender a niche supportive of ectopic bone.
Clinically, HO is often observed in close proximity to connective tissue within myofascial planes and joints. Additionally, transection of the Achilles' tendon in murine models leads to robust ectopic bone through endochondral ossification. Scleraxis, a basic helix-loop-helix transcription factor, is expressed in connective tissues including tendon, ligaments, and perimysium between muscle fibers [6] [7] [8] [9] tendon injury exhibit robust chondrogenic potential both in vitro and when implanted in vivo [10] .
Given the shared presence of scleraxis-expressing cells in both muscle and tendon, we hypothesized that these cells contribute to HO formed after trauma or due to hyperactive BMP signaling.
MATERIALS AND METHODS

Ethics Statement
Procedures involving animals were approved by the Institutional Animal Care and Use Committee of the University of Michigan (PRO0005909) or the Walter Reed Army Institute of Research/ Naval Medical Research Center Institutional Animal Care and Use Committee (12-OUMD-20s).
Animals
All animals were housed in standard conditions. All mice used for burn/tenotomy or BMP sponge implantation were young adult male (6-8 weeks old) C57BL/6 background. Scx-cre/ ROSA26 mTmG , Scx-cre/ROSA26 tdT and Scx-creERT2/ROSA26 tdT mice were used for lineage-tracing experiments. Mice with burn/tenotomy underwent transection of the left hindlimb Achilles' tendon with 30% burn using a metal block heated to 60C applied to the depilated dorsum for 18 seconds [11] . Separately, mice underwent implantation of a human r-BMP loaded collagen scaffold into the gastrocnemius muscle with injection of cardiotoxin [12] . A 3 3 1 mm-thick collagen discs are prepared by punched out of collagen sponge sheets (Resorbable collagen AceSurgical) with 10 ll of recombinant human BMP-2 (1 lg/10 ll; Sigma, St. Louis, MO). An intramuscular pocket in the calf muscles was dissected and one rBMP-2-collagen disc was placed into each pocket. The surgical site was then injected with 100 ll cardiotoxin (0.3 lg/10 ll; Sigma, St. Louis, MO). Mice were euthanized at the indicated timepoints. 
Transgenic Animals
Histology and Imaging
Hind limbs were fixed overnight in 10% neutral buffered formalin and subsequently decalcified in 19% EDTA solution for 4-6 weeks at 48C. Sections were embedded in paraffin or optimal cutting temperature compound (Tissue-Tek; Sakura Finetek) and 5-7 um sections were prepared. Immunofluorescence was carried out using primary antibodies directed against the following: SOX9 (Santa Cruz, Cat No. 17341 or 20095), Osterix, pSmad 1/5 (Santa Cruz, Cat No. 12353), Sca1, PDGFRa, or S100A4. Late timepoint ScxGfp/Scx-creERT2/ ROSA26
tdT sections were stained with anti-tdT (Abcam, Cat No. 62341).
All fluorescently stained images were taken using a Leica Upright SP5X Confocal Microscope or Olympus BX-51 upright light microscope equipped with standard DAPI, 488 nm, and TRITC cubes attached to an Olympus DP-70 high resolution digital camera. Each site was imaged in all channels and overlaid in DPViewer before examination in Adobe Photoshop.
Quantification of Costaining
To quantify staining/costaining, we performed counts on n 5 5 high powered fields (hpfs) chosen at random from across n 5 3 distinct sections. Each high powered field is hand counted and results are tallied from three separate reviewers to ensure consistency. Immunofluorescent staining was regarded as positive, when red/ green channel signal overlapped with or was immediately proximal to DAPI positive staining in the blue channel. For costaining of tdTomato1 with one of more of the fluorescent stains described above, we counted only a triple positive of DAPI1, tdTomato1, and whichever immunofluorescent stain is being evaluated.
Computed Tomography Analysis
Mouse hindlimbs were imaged with micro computed tomography (CT; Siemens Inveon, using 80 kVp, 80 mA, and 1100 ms exposure). Images were reconstructed to demonstrate sites of ectopic bone formation.
Statistical Analysis
Experiments were performed with n 3 using Student's t test. Means and SDs were calculated from numerical data, as presented in the text, figures, and figure legends. All bar graphs are presented as means. Error bars represent 1 SD.
RESULTS
Scleraxis-Lineage Cells Contribute to All Phases of Trauma-Induced HO
We first demonstrated that the Achilles tendon, which is transected in the burn/tenotomy model of trauma-induced HO (tHO) (Supporting Information Fig. S1A ), is marked almost completely by both Scx-cre lineage cells (Scx-cre/ROSA26 mTmG ) and by active expression of Scx (Scx-GFP) prior to injury ( Fig. 1A ; Supporting Information Fig. S1B ). By comparison, intramuscular regions demonstrate a more restrictive pattern with both Scxcre lineage and active Scx expression limited to areas of connective tissue (Supporting Information Fig. S2 ). These regions are the site of ectopic bone formation in our second model of HO formation utilizing an intramuscular BMP-loaded scaffold (bHO).
Using our burn/tenotomy model of tHO, we found that Scx-cre cells contribute to a majority of the fibroproliferative (95.1 6 1.2%) and chondroid (65.8 6 13.0%) regions of developing tHO (Fig. 1B,  Supporting Information Fig. S3 ). To exclude any contribution of trauma-induced activation of scleraxis we then used postnatal, tamoxifen-inducible, scleraxis-lineage restricted reporter mice (Scx-creERT2/tdTomato fl/fl ) with tamoxifen activation ending four days prior to injury ( Fig. 1C; Supporting Information Fig. S4) . These animals were then evaluated for the formation of either tHO or bHO (Fig. 1C) . We found that Scx-creERT2-labeled cells (tdTomato1) contribute to all stages of HO development and could be found in fibroproliferative (50.0 6 25.6%), chondroid (31.0 6 7.8%), and endosteal (49.4 6 18.6) regions of tHO (Fig. 1D, 1E ).
Scx-creERT2 Cells Contribute Directly Endochondral Ossification in Both tHO and bHO
Given the observed contribution of Scx-creERT2 cells to tHO, we wanted to identify whether these cells contribute directly to the process of endochondral ossification by which HO transitions from cartilage to bone. First we identified areas of tHO in Scx-creERT2/tdTomato fl/fl mice demonstrating robust endochondral ossification (Fig. 2A) . These tissues are enriched for chondrogenic (SOX9) and osteogenic (OSX) differentiation markers ( Fig. 2B-2D) . Importantly, tdTomato1 cells in this model expressed both SOX9 and OSX in tHO (Fig. 2B-2D ). Similar findings were observed in our bHO model, although bHO was predictably more ossified with comparatively diminished markers of active endochondral ossification versus tHO (Fig. 2E-2H ).
Scx-creERT2 Cells Display a Mesenchymal Cell Phenotype
Next, we explored the relationship between Scx-creERT2 cells and MSC populations which have previously been shown to contribute to HO. Specifically, we examined PDGFRa and S100A4, which are expressed by Glast-cre cells [5] , and Sca1 which is expressed by Tie21 nonendothelial cells [4] . In both tHO (Fig. 3A-3D ) and bHO ( Fig. 3E-3H ), we noted a high percentage of tdTomato1 cells expressing these markers, however, not all MSC marker1 cells were tdTomato1 consistent with the heterogeneity of HO. Interestingly, when we evaluated the uninjured tissues, while these markers were present, there was no evidence of enrichment in either tendinous or muscular bodies (Supporting Information Fig. S5 ).
Expression of caACVR1 within Scx-Cre Cells Results in HO at the Joints
To clarify whether Scx-cre cells are capable of producing HO, we bred mice with Scx-cre lineage-restricted caACVR1 expression (Scx-cre/caACVR1
fl/wt ). Strikingly, Scx-cre/caACVR1 fl/wt mutant mice developed HO at the joints, with 100% of hindlimbs showing HO at the Achilles' tendon, in the absence of traumatic insult ( Fig. 4A-4D ), although no HO was detectable within muscle (Supporting Information Fig. S6 ). Generation of mutant mice conditionally expressing caACVR1 in muscle-or osteoblast-cells (Ckmm-cre/caACVR1 fl/wt and Col1.creERT/caACVR1 fl/wt ) did not form HO suggesting that BMP receptor hyperactivity in differentiated muscle or osteoblasts is unable to cause HO (Supporting Information Fig. S7 ).
Expression of caACVR1 in Scx-creERT Cells Results in Intramuscular HO After Trauma
Notably, intramuscular HO lesions in patients with fibrodysplasia ossificans progressiva form after muscle trauma. Because HO was not observed within the muscle of mice with caACVR1 in Scx-cre cells without injury, we investigated the effect of injury on caACVR1 expression in these cells.
First, to evaluate the effect of intramuscular inflammation on this system we utilized a separate method of injury from our tHO and bHO, injection of cardiotoxin directly into the muscle body. Using our Scx-GFP reporter, we demonstrated that this was sufficient to drive an increase in Scx expression in areas adjacent to connective tissue (Supporting Information Fig. S8 ). To exclude any contribution of cardiotoxin-induced activation of scleraxis, we then designed a postnatal, tamoxifen-inducible, scleraxis-lineage restricted model of caACVR1 expression (Scx-creERT2/caACVR1 fl/wt ). This system restricted caACVR1 expression to only tamoxifen activated Scx-creERT2 cells. (Fig. 4E) . Routine histology confirmed the presence of heterotopic bone with robust Alcian blue and Alizarin red staining (Fig. 4E) . Immunofluorescent staining for Scx confirmed a normal restricted staining pattern prior to injury with presence of scattered intramuscular Scx1 cells present postcardiotoxin consistent with regions of new HO (Fig. 4F) .
DISCUSSION
These findings indicate that scleraxis-lineage restricted cells have the capacity to form HO in the settings of trauma and with hyperactive BMP receptor activity. Recent studies have identified additional candidate HO including endothelial or nonendothelial Tie21 cells and Glast-Cre cells [3-5, 13, 14] . Using markers such as PDGFRa, Sca1, and S100A4, others have shown that Tie21 and Glast-cre cells which contribute to HO are likely mesenchymal cells [3-5, 13, 14] . Our findings confirm the coexpression of these mesenchymal cell markers in Scx-creERT2 cells, in both trauma or BMP-scaffold implantation. Interestingly, while these markers are not highly enriched in uninjured tissue, they are expressed throughout the early anlagen and persist into regions of hypertrophic chondrocyte formation in both models of HO suggesting that these markers pointing to a conserved role for mesenchymal cells in both processes. The physical source of cells contributing to HO is also of interest. Previous studies identified Scx-cre cells in muscle interstitium and along fascial planes [15] . Our data were consistent with this demonstrating restriction of both active scleraxis and scleraxis lineage to areas of tendon and connective tissue within the muscle. In the setting of trauma and BMP-induced HO, preinjury scleraxis-lineage restricted cells contributing to HO may originate locally and it is possible that the differences in regional sources of Scx-cre cell in uninjured tissue contributes to differences in the prevalence of Scx-cre cells in the HO anlagen between our models. Our findings using the tamoxifen inducible model of caACVR1 expression (Scx-creERT2/caACVR1
fl/wt ) demonstrate that hyperactive BMP signaling restricted to these cells is sufficient to form HO consistent with the idea that these cells form a local/regional pool of prospective HO progenitors.
Interestingly using Scx-cre/caACVR1 fl/wt mice we found that HO was restricted to the tendons, with no evidence of intramuscular HO in the absence of injury. However, we have also found that Scx-cre cells are located intramuscularly and that intramuscular injury was sufficient to cause enrichment of Scx expressing cells in regions adjacent to pre-existing connective tissue planes. Interestingly, even when we controlled for trauma-induced Scx-activation using conditional ScxcreERT2/caACVR1 fl/wt mice, injury was still sufficient to cause intramuscular HO in the background of caACVR1 expression. This suggests either these contributing cells are derived from another source, or that the injury stimulus causes these cells to form HO and highlights the possibility that these cells proliferate in response to trauma, causing an identifiable lesion.
Our findings are just as important for what they are unable to show-the existence of a single progenitor cell which contributes to tHO. Identification of a single progenitor 
